European Union health regulator approves use of Pfizer’s Covid-19 pill for high-risk groups
Zee News
The EMA`s recommendation was sent to the European Commission for a rapid decision applicable in all EU member states.
Brussels: The European Medicines Agency (EMA) has conditionally approved the use of US multinational biotechnology firm Pfizer`s Covid-19 pill for treating adults at risk of severe illness.
The endorsement allows the member states of the European Union (EU) to deploy the drug after the EMA gave guidance for its emergency use late last year, Xinhua news agency reported.
The EMA said in a statement that its Committee for Medicinal Products for Human Use (CHMP) had "recommended granting a conditional marketing authorization for the oral antiviral medicine Paxlovid for treating Covid-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming severe."
